Among these, models of the most aggressive TNBC subtype showed distinct circadian rhythms, challenging the general expectations that the circadian clock is rather dysregulated in highly transformed cancer (Mormont and Levi, 2003; Ye et al, 2018) (Fig. 2). The gene discussed is CLOCK; the disease is cancer.